Roivant Sciences annual r&d spending
2020
2021
2022
2023
2024
2025
Roivant Sciences R&D Spending Growth & History (ROIV)
Roivant Sciences's r&d spending was $681.8M for fiscal 2025.
View full Roivant Sciences company overviewRoivant Sciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2026-03-31 | $681.8M | $131.4M | +23.87% |
| 2024 | 2025-03-31 | $550.4M | $110.5M | +25.12% |
| 2023 | 2024-03-31 | $439.9M | −$14.2M | −3.12% |
| 2022 | 2023-03-31 | $454.1M | −$29.0M | −6.00% |
| 2021 | 2022-03-31 | $483.0M | $246.4M | +104.13% |
| 2020 | 2021-03-31 | $236.6M | — | — |
Roivant Sciences quarterly r&d spending
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-06-30 | $202.0M | $49.1M | +32.11% |
| Q4 2025 | 2026-03-31 | $198.9M | $53.7M | +36.98% |
| Q3 2025 | 2025-12-31 | $165.4M | $23.8M | +16.80% |
| Q2 2025 | 2025-09-30 | $164.6M | $21.5M | +15.02% |
| Q1 2025 | 2025-06-30 | $152.9M | $32.4M | +26.90% |
| Q4 2024 | 2025-03-31 | $145.2M | $53.4M | +58.15% |
| Q3 2024 | 2024-12-31 | $141.6M | $33.4M | +30.93% |
| Q2 2024 | 2024-09-30 | $143.1M | $28.3M | +24.64% |
| Q1 2024 | 2024-06-30 | $120.5M | −$4.6M | −3.70% |
| Q4 2023 | 2024-03-31 | $91.8M | $31.1M | +51.29% |
| Q3 2023 | 2023-12-31 | $108.1M | −$17.4M | −13.85% |
| Q2 2023 | 2023-09-30 | $114.8M | −$17.2M | −13.03% |
| Q1 2023 | 2023-06-30 | $125.1M | −$10.7M | −7.88% |
| Q4 2022 | 2023-03-31 | $60.7M | −$74.4M | −55.06% |
| Q3 2022 | 2022-12-31 | $125.5M | −$11.8M | −8.60% |
| Q2 2022 | 2022-09-30 | $132.0M | −$103,000 | −0.08% |
| Q1 2022 | 2022-06-30 | $135.8M | $57.3M | +73.00% |
| Q4 2021 | 2022-03-31 | $135.1M | — | — |
| Q3 2021 | 2021-12-31 | $137.3M | −$64.9M | −32.10% |
| Q2 2021 | 2021-09-30 | $132.1M | $34.7M | +35.61% |
| Q1 2021 | 2021-06-30 | $78.5M | $19.8M | +33.68% |
| Q3 2020 | 2020-12-31 | $202.3M | — | — |
| Q2 2020 | 2020-09-30 | $97.4M | — | — |
| Q1 2020 | 2020-06-30 | $58.7M | — | — |
Roivant Sciences r&d spending trends
Over the last five fiscal years, Roivant Sciences's r&d spending increased from $236.6M to $681.8M, a change of $445.2M. The latest reported quarter, Q1 2026, shows $202.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Roivant Sciences source filings ↗